Alterations of striatal dopamine D2 receptors contribute to deteriorated response to l-dopa in Parkinson's disease

A [123I]-IBZM SPET study

G. Pizzolato, F. Chierichetti, A. Rossato, A. Cagnin, M. Fabbri, M. Dam, G. Ferlin, L. Battistin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Single photon emission tomography with the ligand [123I]-IBZM was used to image central dopamine D2 receptors in Parkinson's disease patients. The aim was to assess striatal receptor densities in relation to response to L-Dopa therapy. In the parkinsonian patients group who were untreated until SPET study and in the group of patients with a sustained response to chronic L-Dopa, striatal [123I]-IBZM uptake did not differ significantly from mean values of the control group. On the contrary, significantly diminished uptake of [123I]-IBZM was found in the basal ganglia regions of the group of patients who developed a complicated/fluctuating response to chronic L-Dopa treatment. Our results indicate that striatal D2 receptor alterations in Parkinson's disease may contribute to the altered response to L-Dopa.

Original languageEnglish
Pages (from-to)113-122
Number of pages10
JournalJournal of Neural Transmission, Supplement
Issue number45
Publication statusPublished - 1995

Fingerprint

Corpus Striatum
Dihydroxyphenylalanine
Dopamine D2 Receptors
Levodopa
Parkinson Disease
Basal Ganglia
Photons
Tomography
Ligands
Control Groups
3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Pizzolato, G., Chierichetti, F., Rossato, A., Cagnin, A., Fabbri, M., Dam, M., ... Battistin, L. (1995). Alterations of striatal dopamine D2 receptors contribute to deteriorated response to l-dopa in Parkinson's disease: A [123I]-IBZM SPET study. Journal of Neural Transmission, Supplement, (45), 113-122.

Alterations of striatal dopamine D2 receptors contribute to deteriorated response to l-dopa in Parkinson's disease : A [123I]-IBZM SPET study. / Pizzolato, G.; Chierichetti, F.; Rossato, A.; Cagnin, A.; Fabbri, M.; Dam, M.; Ferlin, G.; Battistin, L.

In: Journal of Neural Transmission, Supplement, No. 45, 1995, p. 113-122.

Research output: Contribution to journalArticle

Pizzolato, G, Chierichetti, F, Rossato, A, Cagnin, A, Fabbri, M, Dam, M, Ferlin, G & Battistin, L 1995, 'Alterations of striatal dopamine D2 receptors contribute to deteriorated response to l-dopa in Parkinson's disease: A [123I]-IBZM SPET study', Journal of Neural Transmission, Supplement, no. 45, pp. 113-122.
Pizzolato, G. ; Chierichetti, F. ; Rossato, A. ; Cagnin, A. ; Fabbri, M. ; Dam, M. ; Ferlin, G. ; Battistin, L. / Alterations of striatal dopamine D2 receptors contribute to deteriorated response to l-dopa in Parkinson's disease : A [123I]-IBZM SPET study. In: Journal of Neural Transmission, Supplement. 1995 ; No. 45. pp. 113-122.
@article{c0963d6150904a3c938aea6a78c308c4,
title = "Alterations of striatal dopamine D2 receptors contribute to deteriorated response to l-dopa in Parkinson's disease: A [123I]-IBZM SPET study",
abstract = "Single photon emission tomography with the ligand [123I]-IBZM was used to image central dopamine D2 receptors in Parkinson's disease patients. The aim was to assess striatal receptor densities in relation to response to L-Dopa therapy. In the parkinsonian patients group who were untreated until SPET study and in the group of patients with a sustained response to chronic L-Dopa, striatal [123I]-IBZM uptake did not differ significantly from mean values of the control group. On the contrary, significantly diminished uptake of [123I]-IBZM was found in the basal ganglia regions of the group of patients who developed a complicated/fluctuating response to chronic L-Dopa treatment. Our results indicate that striatal D2 receptor alterations in Parkinson's disease may contribute to the altered response to L-Dopa.",
author = "G. Pizzolato and F. Chierichetti and A. Rossato and A. Cagnin and M. Fabbri and M. Dam and G. Ferlin and L. Battistin",
year = "1995",
language = "English",
pages = "113--122",
journal = "Journal of Neural Transmission, Supplement",
issn = "0303-6995",
publisher = "Springer Wien",
number = "45",

}

TY - JOUR

T1 - Alterations of striatal dopamine D2 receptors contribute to deteriorated response to l-dopa in Parkinson's disease

T2 - A [123I]-IBZM SPET study

AU - Pizzolato, G.

AU - Chierichetti, F.

AU - Rossato, A.

AU - Cagnin, A.

AU - Fabbri, M.

AU - Dam, M.

AU - Ferlin, G.

AU - Battistin, L.

PY - 1995

Y1 - 1995

N2 - Single photon emission tomography with the ligand [123I]-IBZM was used to image central dopamine D2 receptors in Parkinson's disease patients. The aim was to assess striatal receptor densities in relation to response to L-Dopa therapy. In the parkinsonian patients group who were untreated until SPET study and in the group of patients with a sustained response to chronic L-Dopa, striatal [123I]-IBZM uptake did not differ significantly from mean values of the control group. On the contrary, significantly diminished uptake of [123I]-IBZM was found in the basal ganglia regions of the group of patients who developed a complicated/fluctuating response to chronic L-Dopa treatment. Our results indicate that striatal D2 receptor alterations in Parkinson's disease may contribute to the altered response to L-Dopa.

AB - Single photon emission tomography with the ligand [123I]-IBZM was used to image central dopamine D2 receptors in Parkinson's disease patients. The aim was to assess striatal receptor densities in relation to response to L-Dopa therapy. In the parkinsonian patients group who were untreated until SPET study and in the group of patients with a sustained response to chronic L-Dopa, striatal [123I]-IBZM uptake did not differ significantly from mean values of the control group. On the contrary, significantly diminished uptake of [123I]-IBZM was found in the basal ganglia regions of the group of patients who developed a complicated/fluctuating response to chronic L-Dopa treatment. Our results indicate that striatal D2 receptor alterations in Parkinson's disease may contribute to the altered response to L-Dopa.

UR - http://www.scopus.com/inward/record.url?scp=0028971346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028971346&partnerID=8YFLogxK

M3 - Article

SP - 113

EP - 122

JO - Journal of Neural Transmission, Supplement

JF - Journal of Neural Transmission, Supplement

SN - 0303-6995

IS - 45

ER -